Skip to main content
Erschienen in: Pathology & Oncology Research 2/2010

01.06.2010

Oxidant/Antioxidant Status, Lipids and Hormonal Profile in Overweight Women with Breast Cancer

verfasst von: Naima Badid, Fatima Zohra Baba Ahmed, Hafida Merzouk, Slimane Belbraouet, Nassima Mokhtari, Sid Ahmed Merzouk, Riad Benhabib, Djalloul Hamzaoui, Michel Narce

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

This study was carried out to determine the relationships between leptin concentrations, lipid alterations, oxidant/ antioxidant status, in vitro LDL oxidizability and LDL-fatty acid composition in overweight breast cancer patients. Glucose, insulin, leptin, lipids, LDL-cholesteryl ester fatty acids, markers of oxidant status (MDA, Hydroperoxides, carbonyl proteins, conjugated dienes) and markers of antioxidant status (vitamins A, C, E, erythrocyte activities of the enzymes superoxide dismutase, SOD, catalase, glutathione peroxidase,GPx, and glutathione reductase, GR and the serum total antioxidant status, ORAC) were investigated in breast cancer patients and in control women. Our findings showed that insulin, leptin, triglyceride, cholesterol and LDL-C concentrations were increased in patients compared to controls. ORAC and vitamin C and E values were lower while plasma hydroperoxide, carbonyl protein and conjugated diene levels, SOD and GPx activities were higher than in controls. Alterations in LDL-fatty acid composition were associated with their enhanced oxidative susceptibility. There were significant positive correlations between leptin concentrations and LDL-C, hydroperoxides, carbonyl proteins, SOD activity, baseline conjugated diene levels and oxidation rate, and significant negative correlations between leptin and ORAC, lag time and LDL-PUFA in patients. In conclusion, breast cancer is associated with lipid alterations and enhanced oxidative stress linked to high leptin levels in overweight.
Literatur
1.
Zurück zum Zitat World Health Organization, International Agency for Research on Cancer (2002) IARC handbooks of cancer prevention: breast cancer screening. IRAC, Layon, pp 1–7 World Health Organization, International Agency for Research on Cancer (2002) IARC handbooks of cancer prevention: breast cancer screening. IRAC, Layon, pp 1–7
2.
Zurück zum Zitat Kaaks R (1996) Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7:605–625CrossRefPubMed Kaaks R (1996) Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7:605–625CrossRefPubMed
3.
Zurück zum Zitat Nelson NJ (2006) Migrant studies aid the search for factors linked to breast cancer risk. J Natl Cancer Inst 98:436–438PubMed Nelson NJ (2006) Migrant studies aid the search for factors linked to breast cancer risk. J Natl Cancer Inst 98:436–438PubMed
4.
Zurück zum Zitat Kang DH (2002) Oxidative stress, DNA damage, and breast cancer. AACN Clin Issues 13:540–549CrossRefPubMed Kang DH (2002) Oxidative stress, DNA damage, and breast cancer. AACN Clin Issues 13:540–549CrossRefPubMed
6.
Zurück zum Zitat Ahn J, Nowell S, McCann SE, Yu J et al (2006) Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev 15:1217–1222CrossRefPubMed Ahn J, Nowell S, McCann SE, Yu J et al (2006) Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev 15:1217–1222CrossRefPubMed
7.
Zurück zum Zitat Saadatian-Elahi M, Norat T, Goudable J, Riboli E (2004) Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis. Int J Cancer 111:584–591CrossRefPubMed Saadatian-Elahi M, Norat T, Goudable J, Riboli E (2004) Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis. Int J Cancer 111:584–591CrossRefPubMed
8.
Zurück zum Zitat Abu-Bedair FA, El-Gamal BA, Ibrahim NA, El-Aaser AA (2003) Serum lipids and tissue DNA content in Egyptian female breast cancer patients. Jpn J Clin Oncol 33:278–282CrossRefPubMed Abu-Bedair FA, El-Gamal BA, Ibrahim NA, El-Aaser AA (2003) Serum lipids and tissue DNA content in Egyptian female breast cancer patients. Jpn J Clin Oncol 33:278–282CrossRefPubMed
9.
Zurück zum Zitat Am F, Branchi A, Sommaviva D (2000) Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res 30:141–145CrossRef Am F, Branchi A, Sommaviva D (2000) Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res 30:141–145CrossRef
10.
Zurück zum Zitat Merzouk S, Hichami A, Sari A et al (2004) Impaired oxidant/antioxidant status and LDL-fatty acid composition are associated with increased susceptibility to peroxidation of LDL in diabetic patients. J Gen Physiol Biophys 23:387–399 Merzouk S, Hichami A, Sari A et al (2004) Impaired oxidant/antioxidant status and LDL-fatty acid composition are associated with increased susceptibility to peroxidation of LDL in diabetic patients. J Gen Physiol Biophys 23:387–399
11.
Zurück zum Zitat Peacock SL, White E, Daling JR, Voigt LF, Malone KE (1999) Relation between obesity and breast cancer in young women. Am J Epidemiol 149:339–346PubMed Peacock SL, White E, Daling JR, Voigt LF, Malone KE (1999) Relation between obesity and breast cancer in young women. Am J Epidemiol 149:339–346PubMed
12.
Zurück zum Zitat Urakawa H, Katsuki A, Sumida Y et al (2003) Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 88:4673–4676CrossRefPubMed Urakawa H, Katsuki A, Sumida Y et al (2003) Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 88:4673–4676CrossRefPubMed
13.
Zurück zum Zitat Schindler TH, Cardenas J, Prior JO et al (2006) Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol 47:1188–1195CrossRefPubMed Schindler TH, Cardenas J, Prior JO et al (2006) Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol 47:1188–1195CrossRefPubMed
14.
Zurück zum Zitat Maeso Fortuny MC, Brito Díaz B, Cabrera de León A (2006) Leptin, estrogens and cancer. Mini Rev Med Chem 6:897–907CrossRefPubMed Maeso Fortuny MC, Brito Díaz B, Cabrera de León A (2006) Leptin, estrogens and cancer. Mini Rev Med Chem 6:897–907CrossRefPubMed
15.
Zurück zum Zitat Sulkowska M, Golaszewska J, Wincewicz A, Koda M, Baltaziak M, Sulkowski S (2006) Leptin—from regulation of fat metabolism to stimulation of breast cancer growth. Pathol Oncol Res 12:69–72CrossRefPubMed Sulkowska M, Golaszewska J, Wincewicz A, Koda M, Baltaziak M, Sulkowski S (2006) Leptin—from regulation of fat metabolism to stimulation of breast cancer growth. Pathol Oncol Res 12:69–72CrossRefPubMed
16.
Zurück zum Zitat Roe JH, Kuether CA (1943) The determination of ascorbic acid in whole blood and urine through the 2, 4-dinitrophenylhydrazine derivatives of dehydroascorbic acid. J Biol Chem 147:399–407 Roe JH, Kuether CA (1943) The determination of ascorbic acid in whole blood and urine through the 2, 4-dinitrophenylhydrazine derivatives of dehydroascorbic acid. J Biol Chem 147:399–407
17.
Zurück zum Zitat Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis, 2nd edn. Verlag Chemie GmbH, Weinheim Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis, 2nd edn. Verlag Chemie GmbH, Weinheim
18.
Zurück zum Zitat Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterizations of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169PubMed Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterizations of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169PubMed
19.
Zurück zum Zitat Goldberg DM, Spooner RJ (1992) Glutathione reductase. In: Bergmeyer HB (ed) Methods of enzymatic analysis, vol 3, 3rd edn. Verlag Chemie GmbH, Weinheim, pp 258–265 Goldberg DM, Spooner RJ (1992) Glutathione reductase. In: Bergmeyer HB (ed) Methods of enzymatic analysis, vol 3, 3rd edn. Verlag Chemie GmbH, Weinheim, pp 258–265
20.
Zurück zum Zitat Elstner EF, Youngman RJ, Obwad W (1983) Superoxide dismutase. In: Bergmeyer HB (ed) Methods of enzymatic analysis, 3rd edn. Verlag Chemie GmbH, Weinheim, vol 3, pp 293–302 Elstner EF, Youngman RJ, Obwad W (1983) Superoxide dismutase. In: Bergmeyer HB (ed) Methods of enzymatic analysis, 3rd edn. Verlag Chemie GmbH, Weinheim, vol 3, pp 293–302
21.
Zurück zum Zitat Nourooz-Zadeh J, Tajaddini-Sarmadi J, Ling KLE, Wolff PS (1996) Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations. Biochem J 313:781–786PubMed Nourooz-Zadeh J, Tajaddini-Sarmadi J, Ling KLE, Wolff PS (1996) Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations. Biochem J 313:781–786PubMed
22.
Zurück zum Zitat Levine RL, Garland D, Oliver CN et al (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–478CrossRefPubMed Levine RL, Garland D, Oliver CN et al (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–478CrossRefPubMed
23.
Zurück zum Zitat Lowry OH, Rosebrough NJ, Farr AL, Randall RI (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265–275PubMed Lowry OH, Rosebrough NJ, Farr AL, Randall RI (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265–275PubMed
24.
Zurück zum Zitat Esterbauer H, Striegl G, Puhl H, Rotheneder M (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun 6:67–75CrossRef Esterbauer H, Striegl G, Puhl H, Rotheneder M (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun 6:67–75CrossRef
25.
Zurück zum Zitat Rose DP, Haffner SM, Baillargeon J (2007) Adiposity, the metabolic syndrome, and breast cancer in African–American and White American women. Endocr Rev 28:763–777CrossRefPubMed Rose DP, Haffner SM, Baillargeon J (2007) Adiposity, the metabolic syndrome, and breast cancer in African–American and White American women. Endocr Rev 28:763–777CrossRefPubMed
26.
Zurück zum Zitat Tessitore L, Vizio B, Pesola D et al (2004) Adipocyte expression and circulating levels of leptin increase in both gynaecological and breast cancer patients. Int J Oncol 24:1529–1535PubMed Tessitore L, Vizio B, Pesola D et al (2004) Adipocyte expression and circulating levels of leptin increase in both gynaecological and breast cancer patients. Int J Oncol 24:1529–1535PubMed
27.
Zurück zum Zitat Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96:1152–1160PubMedCrossRef Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96:1152–1160PubMedCrossRef
28.
Zurück zum Zitat Dhaval SF (2008) Significance of alterations in plasma lipid profile levels in breast cancer. Integr Cancer Ther 7:33–41CrossRef Dhaval SF (2008) Significance of alterations in plasma lipid profile levels in breast cancer. Integr Cancer Ther 7:33–41CrossRef
29.
Zurück zum Zitat Hasija K, Bagga HK (2005) Alterations of serum cholesterol and serum lipoprotein in breast cancer of women. Indian J Clin Biochem 20:61–66CrossRef Hasija K, Bagga HK (2005) Alterations of serum cholesterol and serum lipoprotein in breast cancer of women. Indian J Clin Biochem 20:61–66CrossRef
30.
Zurück zum Zitat Gooden PJ, Boyd NF, Hanna W, Hartwick W, Murray D, Qizilbash A (1997) Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer 27:284–292CrossRef Gooden PJ, Boyd NF, Hanna W, Hartwick W, Murray D, Qizilbash A (1997) Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer 27:284–292CrossRef
31.
Zurück zum Zitat Ambrosone CB (2000) Oxidants and antioxidants in breast cancer. Antioxid Redox Signal 2:903–917CrossRefPubMed Ambrosone CB (2000) Oxidants and antioxidants in breast cancer. Antioxid Redox Signal 2:903–917CrossRefPubMed
32.
Zurück zum Zitat Rossner P, Terry MB, Gammon MD et al (2007) Plasma protein carbonyl levels and breast cancer risk. J Cell Mol Med 11:1138–1148CrossRefPubMed Rossner P, Terry MB, Gammon MD et al (2007) Plasma protein carbonyl levels and breast cancer risk. J Cell Mol Med 11:1138–1148CrossRefPubMed
33.
Zurück zum Zitat Bougnoux P, Giraudeau B, Couet C (2006) Diet, cancer, and the lipidome. Cancer Epidemiol Biomarkers Prev 15:416–421CrossRefPubMed Bougnoux P, Giraudeau B, Couet C (2006) Diet, cancer, and the lipidome. Cancer Epidemiol Biomarkers Prev 15:416–421CrossRefPubMed
34.
Zurück zum Zitat Surapaneni KM, Gopan CS (2007) Status of lipid peroxidation and antioxidant enzymes in patients with carcinoma of breast. JMSR 15:21–24 Surapaneni KM, Gopan CS (2007) Status of lipid peroxidation and antioxidant enzymes in patients with carcinoma of breast. JMSR 15:21–24
35.
Zurück zum Zitat Delimaris I, Faviou E, Antonakos G, Stathopoulou E, Zachari A, Dionyssiou-Asteriou A (2007) Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. Clin Biochem 40:1129–1134CrossRefPubMed Delimaris I, Faviou E, Antonakos G, Stathopoulou E, Zachari A, Dionyssiou-Asteriou A (2007) Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. Clin Biochem 40:1129–1134CrossRefPubMed
36.
Zurück zum Zitat Shannon J, King IB, Moshofsky R et al (2007) Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China. Am J Clin Nutr 85:1090–1097PubMed Shannon J, King IB, Moshofsky R et al (2007) Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China. Am J Clin Nutr 85:1090–1097PubMed
37.
Zurück zum Zitat Lu S, Archer MC (2005) Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer. Carcinogenesis 26:153–157CrossRefPubMed Lu S, Archer MC (2005) Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer. Carcinogenesis 26:153–157CrossRefPubMed
Metadaten
Titel
Oxidant/Antioxidant Status, Lipids and Hormonal Profile in Overweight Women with Breast Cancer
verfasst von
Naima Badid
Fatima Zohra Baba Ahmed
Hafida Merzouk
Slimane Belbraouet
Nassima Mokhtari
Sid Ahmed Merzouk
Riad Benhabib
Djalloul Hamzaoui
Michel Narce
Publikationsdatum
01.06.2010
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 2/2010
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-009-9199-0

Weitere Artikel der Ausgabe 2/2010

Pathology & Oncology Research 2/2010 Zur Ausgabe

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.